Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Prot# TMC125-C229: An Open-Label Trial with TMC125 in HIV-1 Infected Subjects, Who Were Randomized to a TMC125 Treatment Arm in a Sponsor-Selected TMC125 Trial and Were Treated for at Least 48 Weeks
Murphy, Robert Leo
(PD/PI)
Medicine, Infectious Diseases Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
9/7/05
→
8/12/08
Funding
PPD Development
(TMC125-C229)
Tibotec Pharmaceuticals Ltd.
(TMC125-C229)
View all
View less